Very intere4sting upside here when a private biotech acquires a shell and is a potential reverse merger candidate due to low float, OS and serious funding issues. Only 33 million float and 90 million O/S which is peanuts IMHO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.